• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[年龄相关性黄斑营养不良的发病机制治疗]

[The pathogenetic treatment of age-related macular dystrophies].

作者信息

Smoliakova G P

出版信息

Oftalmol Zh. 1989(8):466-9.

PMID:2636346
Abstract

The paper analyses results after medicamentous treatment of 181 patients with senile macular dystrophies, using methods of pharmacologic correction of sympathetic-adrenal (phosphaden, pyridoxine, ethymisole, ascorbic acid), callicreine-kinin (andecaline, paramidine, cinnarisine) activities and methods of traditional therapy consisting of vasodilative, antisclerotic preparations, vitamins and biostimulants. The comparative analysis has shown that the above preparations normalize KA metabolism and processes of kininogenesis. Stabilization of the dystrophic process is achieved in 82.6% of cases as compared with 71.4% of patients treated by traditional methods; the duration of the therapeutic effect after one course of treatment increases by 3-4 months; the incidence of appearance of transudative-hemorrhagic changes in the central segments of the eye fundus in the presence of atrophic dystrophies of the retina decreases by three times.

摘要

本文分析了181例老年黄斑营养不良患者药物治疗后的结果,采用了交感 - 肾上腺(磷酸腺、吡哆醇、乙嘧唑、抗坏血酸)活性的药理纠正方法、激肽释放酶 - 激肽(安地卡林、对脒基苯甲醚、桂利嗪)活性的药理纠正方法,以及由血管扩张剂、抗硬化制剂、维生素和生物刺激剂组成的传统治疗方法。对比分析表明,上述制剂可使激肽原(KA)代谢和激肽生成过程正常化。与采用传统方法治疗的71.4%的患者相比,82.6%的病例实现了营养不良过程的稳定;一个疗程治疗后的治疗效果持续时间增加了3 - 4个月;在视网膜萎缩性营养不良存在的情况下,眼底中央部分出现渗出性 - 出血性变化的发生率降低了两倍。 (注:最后一句“降低了两倍”表述有误,中文一般说“降低了二分之一”,这里按照原文翻译)

相似文献

1
[The pathogenetic treatment of age-related macular dystrophies].[年龄相关性黄斑营养不良的发病机制治疗]
Oftalmol Zh. 1989(8):466-9.
2
[Taufon and emoksipin in the combined treatment of sclerotic macular dystrophies].
Oftalmol Zh. 1989(8):463-5.
3
[Phosphaden in the treatment of patients with age-related macular dystrophies].[磷酸腺嘌呤治疗年龄相关性黄斑营养不良患者]
Oftalmol Zh. 1984(8):489-91.
4
[Age-related macular degeneration after retinal detachment surgery].视网膜脱离手术后的年龄相关性黄斑变性
J Fr Ophtalmol. 1989;12(10):701-7.
5
LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.LAST II:萎缩性年龄相关性黄斑变性患者黄斑色素光密度对叶黄素膳食补充剂的不同时间反应。
Optometry. 2007 May;78(5):213-9. doi: 10.1016/j.optm.2006.10.019.
6
Effects of melatonin in age-related macular degeneration.褪黑素在年龄相关性黄斑变性中的作用。
Ann N Y Acad Sci. 2005 Dec;1057:384-92. doi: 10.1196/annals.1356.029.
7
Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration.年龄相关性黄斑变性地图样萎缩型中的萎缩扩大与视力丧失
Ophthalmology. 1999 Sep;106(9):1768-79. doi: 10.1016/S0161-6420(99)90340-8.
8
Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration patients treated with ranibizumab.雷珠单抗治疗的新生血管性年龄相关性黄斑变性患者经微视野计测量的视网膜功能变化
Retina. 2009 Mar;29(3):329-34. doi: 10.1097/IAE.0b013e31819093e6.
9
[Evaluation of the therapeutic action of DOPA and phosphaden in experimental dystrophic changes of the retina induced by disorders of the functional state of the sympatho-adrenal system].[评估多巴和磷酸腺对交感-肾上腺系统功能状态紊乱所致视网膜实验性营养不良性变化的治疗作用]
Oftalmol Zh. 1988(1):42-5.
10
[Pathogenesis of age-related macular degeneration].[年龄相关性黄斑变性的发病机制]
Duodecim. 2009;125(2):145-53.